Literature DB >> 29360563

Adrenergic receptor stimulation suppresses oxidative metabolism in isolated rat islets and Min6 cells.

Amy C Kelly1, Leticia E Camacho1, Ken Pendarvis1, Hailey M Davenport1, Nathan R Steffens1, Kate E Smith2, Craig S Weber3, Ronald M Lynch3, Klearchos K Papas2, Sean W Limesand4.   

Abstract

Insulin secretion is stimulated by glucose metabolism and inhibited by catecholamines through adrenergic receptor stimulation. We determined whether catecholamines suppress oxidative metabolism in β-cells through adrenergic receptors. In Min6 cells and isolated rat islets, epinephrine decreased oxygen consumption rates compared to vehicle control or co-administration of epinephrine with α2-adrenergic receptor antagonist yohimbine. Epinephrine also decreased forskolin-stimulated oxygen consumption rates, indicating cAMP dependent and independent actions. Furthermore, glucose oxidation rates were decreased with epinephrine, independent of the exocytosis of insulin, which was blocked with yohimbine. We evaluated metabolic targets through proteomic analysis after 4 h epinephrine exposure that revealed 466 differentially expressed proteins that were significantly enriched for processes including oxidative metabolism, protein turnover, exocytosis, and cell proliferation. These results demonstrate that acute α2-adrenergic stimulation suppresses glucose oxidation in β-cells independent of nutrient availability and insulin exocytosis, while cAMP concentrations are elevated. Proteomics and immunoblots revealed changes in electron transport chain proteins that were correlated with lower metabolic reducing equivalents, intracellular ATP concentrations, and altered mitochondrial membrane potential implicating a new role for adrenergic control of mitochondrial function and ultimately insulin secretion.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adrenergic receptor; Insulin secretion; Oxidative phosphorylation; Pancreatic Islet; Proteomics; β-cell metabolism

Mesh:

Substances:

Year:  2018        PMID: 29360563      PMCID: PMC6045463          DOI: 10.1016/j.mce.2018.01.012

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Chronic Adrenergic Signaling Causes Abnormal RNA Expression of Proliferative Genes in Fetal Sheep Islets.

Authors:  Amy C Kelly; Christopher A Bidwell; Xiaochuan Chen; Antoni R Macko; Miranda J Anderson; Sean W Limesand
Journal:  Endocrinology       Date:  2018-10-01       Impact factor: 4.736

2.  Augmented glucose production is not contingent on high catecholamines in fetal sheep with IUGR.

Authors:  Melissa A Davis; Leticia E Camacho; Alexander L Pendleton; Andrew T Antolic; Rosa I Luna-Ramirez; Amy C Kelly; Nathan R Steffens; Miranda J Anderson; Sean W Limesand
Journal:  J Endocrinol       Date:  2021-05-13       Impact factor: 4.286

3.  Tissue-specific responses that constrain glucose oxidation and increase lactate production with the severity of hypoxemia in fetal sheep.

Authors:  Amanda K Jones; Dong Wang; David A Goldstrohm; Laura D Brown; Paul J Rozance; Sean W Limesand; Stephanie R Wesolowski
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-12-27       Impact factor: 4.310

4.  Insulinoma-derived pseudo-islets for diabetes research.

Authors:  Nathaniel J Hart; Craig Weber; Nicholas Price; Alma Banuelos; Madison Schultz; Barry Huey; Emily Harnois; Cyonna Gibson; Leah V Steyn; Klearchos K Papas; Ronald M Lynch
Journal:  Am J Physiol Cell Physiol       Date:  2021-06-09       Impact factor: 5.282

5.  Impact of thermal stress on placental function and fetal physiology.

Authors:  Sean W Limesand; Leticia E Camacho; Amy C Kelly; Andrew T Antolic
Journal:  Anim Reprod       Date:  2018-08-03       Impact factor: 1.810

6.  Pancreatic Islets Exhibit Dysregulated Adaptation of Insulin Secretion after Chronic Epinephrine Exposure.

Authors:  Rui Li; Huichai Huang; Sean W Limesand; Xiaochuan Chen
Journal:  Curr Issues Mol Biol       Date:  2021-05-28       Impact factor: 2.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.